PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CH5.L vs. LHTC.DE
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


CH5.LLHTC.DE
YTD Return-61.66%8.39%
1Y Return-60.41%12.48%
3Y Return (Ann)-25.81%3.64%
5Y Return (Ann)-12.45%7.14%
10Y Return (Ann)-2.97%7.54%
Sharpe Ratio-0.951.11
Sortino Ratio-0.891.58
Omega Ratio0.581.20
Calmar Ratio-0.921.12
Martin Ratio-1.433.97
Ulcer Index42.23%3.30%
Daily Std Dev63.53%11.82%
Max Drawdown-65.59%-40.53%
Current Drawdown-65.55%-11.67%

Correlation

-0.50.00.51.00.9

The correlation between CH5.L and LHTC.DE is 0.85, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.

Performance

CH5.L vs. LHTC.DE - Performance Comparison

In the year-to-date period, CH5.L achieves a -61.66% return, which is significantly lower than LHTC.DE's 8.39% return. Over the past 10 years, CH5.L has underperformed LHTC.DE with an annualized return of -2.97%, while LHTC.DE has yielded a comparatively higher 7.54% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%JuneJulyAugustSeptemberOctoberNovember
-65.38%
-6.09%
CH5.L
LHTC.DE

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CH5.L vs. LHTC.DE - Expense Ratio Comparison

CH5.L has a 0.25% expense ratio, which is lower than LHTC.DE's 0.30% expense ratio.


LHTC.DE
Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc
Expense ratio chart for LHTC.DE: current value at 0.30% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.30%
Expense ratio chart for CH5.L: current value at 0.25% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.25%

Risk-Adjusted Performance

CH5.L vs. LHTC.DE - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CH5.L
Sharpe ratio
The chart of Sharpe ratio for CH5.L, currently valued at -0.94, compared to the broader market-2.000.002.004.006.00-0.94
Sortino ratio
The chart of Sortino ratio for CH5.L, currently valued at -0.87, compared to the broader market-2.000.002.004.006.008.0010.0012.00-0.87
Omega ratio
The chart of Omega ratio for CH5.L, currently valued at 0.60, compared to the broader market1.001.502.002.503.000.60
Calmar ratio
The chart of Calmar ratio for CH5.L, currently valued at -0.92, compared to the broader market0.005.0010.0015.00-0.92
Martin ratio
The chart of Martin ratio for CH5.L, currently valued at -1.43, compared to the broader market0.0020.0040.0060.0080.00100.00120.00-1.43
LHTC.DE
Sharpe ratio
The chart of Sharpe ratio for LHTC.DE, currently valued at 0.71, compared to the broader market-2.000.002.004.006.000.71
Sortino ratio
The chart of Sortino ratio for LHTC.DE, currently valued at 1.08, compared to the broader market-2.000.002.004.006.008.0010.0012.001.08
Omega ratio
The chart of Omega ratio for LHTC.DE, currently valued at 1.13, compared to the broader market1.001.502.002.503.001.13
Calmar ratio
The chart of Calmar ratio for LHTC.DE, currently valued at 0.58, compared to the broader market0.005.0010.0015.000.59
Martin ratio
The chart of Martin ratio for LHTC.DE, currently valued at 2.22, compared to the broader market0.0020.0040.0060.0080.00100.00120.002.22

CH5.L vs. LHTC.DE - Sharpe Ratio Comparison

The current CH5.L Sharpe Ratio is -0.95, which is lower than the LHTC.DE Sharpe Ratio of 1.11. The chart below compares the historical Sharpe Ratios of CH5.L and LHTC.DE, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.00-0.500.000.501.001.502.002.50JuneJulyAugustSeptemberOctoberNovember
-0.94
0.71
CH5.L
LHTC.DE

Dividends

CH5.L vs. LHTC.DE - Dividend Comparison

Neither CH5.L nor LHTC.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

CH5.L vs. LHTC.DE - Drawdown Comparison

The maximum CH5.L drawdown since its inception was -65.59%, which is greater than LHTC.DE's maximum drawdown of -40.53%. Use the drawdown chart below to compare losses from any high point for CH5.L and LHTC.DE. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-65.41%
-15.25%
CH5.L
LHTC.DE

Volatility

CH5.L vs. LHTC.DE - Volatility Comparison

Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) has a higher volatility of 3.97% compared to Lyxor STOXX Europe 600 Healthcare UCITS ETF Acc (LHTC.DE) at 3.67%. This indicates that CH5.L's price experiences larger fluctuations and is considered to be riskier than LHTC.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%JuneJulyAugustSeptemberOctoberNovember
3.97%
3.67%
CH5.L
LHTC.DE